172 related articles for article (PubMed ID: 24477561)
1. Rotary bioreactor culture can discern specific behavior phenotypes in Trk-null and Trk-expressing neuroblastoma cell lines.
Redden RA; Iyer R; Brodeur GM; Doolin EJ
In Vitro Cell Dev Biol Anim; 2014 Mar; 50(3):188-93. PubMed ID: 24477561
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
4. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
5. The effect of P75 on Trk receptors in neuroblastomas.
Ho R; Minturn JE; Simpson AM; Iyer R; Light JE; Evans AE; Brodeur GM
Cancer Lett; 2011 Jun; 305(1):76-85. PubMed ID: 21419569
[TBL] [Abstract][Full Text] [Related]
6. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
Artim SC; Kiyatkin A; Lemmon MA
Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
9. Microgravity assay of neuroblastoma: in vitro aggregation kinetics and organoid morphology correlate with MYCN expression.
Redden RA; Doolin EJ
In Vitro Cell Dev Biol Anim; 2011 Apr; 47(4):312-7. PubMed ID: 21384249
[TBL] [Abstract][Full Text] [Related]
10. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):569-72. PubMed ID: 11107119
[TBL] [Abstract][Full Text] [Related]
11. Identification of dynamic proteome changes upon ligand activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometry.
Sitek B; Apostolov O; Stühler K; Pfeiffer K; Meyer HE; Eggert A; Schramm A
Mol Cell Proteomics; 2005 Mar; 4(3):291-9. PubMed ID: 15654083
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies.
Evangelopoulos ME; Weis J; Kruttgen A
J Neurooncol; 2004 Jan; 66(1-2):101-10. PubMed ID: 15015775
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
Kim CJ; Matsuo T; Lee KH; Thiele CJ
Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
[TBL] [Abstract][Full Text] [Related]
15. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
16. Trk receptor expression and inhibition in neuroblastomas.
Brodeur GM; Minturn JE; Ho R; Simpson AM; Iyer R; Varela CR; Light JE; Kolla V; Evans AE
Clin Cancer Res; 2009 May; 15(10):3244-50. PubMed ID: 19417027
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.
Fung W; Hasan MY; Loh AH; Chua JH; Yong MH; Knight L; Hwang WS; Chan MY; Seow WT; Jacobsen AS; Chui CH
Pediatr Hematol Oncol; 2011 Oct; 28(7):571-8. PubMed ID: 21728718
[TBL] [Abstract][Full Text] [Related]
19. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
20. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
